Pelletier J P, Martel-Pelletier J
University of Montreal, Rheumatic Diseases Unit Research Laboratory, Notre-Dame Hospital Research Center, PQ, Canada.
J Rheumatol Suppl. 1991 Feb;27:127-30.
We examined the in vivo effects of prophylactic intraarticular corticosteroid injections and nonsteroidal antiinflammatory drugs (NSAID) (tiaprofenic acid) oral administration on cartilage lesions of osteoarthritis (OA) and osteophyte formation in 18 dogs in which the anterior cruciate ligament had been sectioned. Six of the dogs received no treatment; 5 had 3 injections of 5 mg triamcinolone hexacetonide at 0, 4 and 8 weeks postsurgery; and 7 were treated orally with 5 mg/kg/day tiaprofenic acid. The untreated dogs developed cartilage lesions on the tibial plateaus and femoral condyles with prominent osteophytes on both lateral and medial condyles. The number and size of the osteophytes were significantly reduced in the triamcinolone treated dogs (p less than 0.0001). Moreover, both triamcinolone and tiaprofenic acid treated groups showed a decrease in the grade and size of tibial plateau lesions, compared to the untreated dogs. There was a similar and statistically significant decrease in lesion size when the treated dogs (about 50 mm2) were compared to the untreated dogs (77 mm2). Histological studies revealed that both drugs also significantly decreased the severity of OA structural changes of the cartilage on both femoral condyles and tibial plateaus, although the response to triamcinolone was more pronounced. Our data confirm the effectiveness of prophylactic treatment with corticosteroids and tiaprofenic acid in preventing the progression of OA lesions in the dog model.
我们研究了预防性关节内注射皮质类固醇和口服非甾体抗炎药(NSAID)(噻丙吩酸)对18只切断前交叉韧带的犬骨关节炎(OA)软骨损伤和骨赘形成的体内影响。6只犬未接受治疗;5只犬在术后0、4和8周接受3次5 mg己曲安奈德注射;7只犬口服5 mg/kg/天的噻丙吩酸。未治疗的犬在胫骨平台和股骨髁出现软骨损伤,内外侧髁均有明显骨赘。曲安奈德治疗的犬骨赘数量和大小显著减少(p小于0.0001)。此外,与未治疗的犬相比,曲安奈德和噻丙吩酸治疗组的胫骨平台损伤程度和大小均有所降低。治疗的犬(约50 mm²)与未治疗的犬(77 mm²)相比,损伤大小有类似且具有统计学意义的降低。组织学研究表明,两种药物也显著降低了股骨髁和胫骨平台软骨OA结构变化的严重程度,尽管对曲安奈德的反应更明显。我们的数据证实了皮质类固醇和噻丙吩酸预防性治疗在预防犬模型OA病变进展方面的有效性。